Special Panels Present Significant Opportunity at OneMedForum SF 2012

OneMedForum SF 2012 is quickly approaching. In addition to special Sector Reports in 8 healthcare sectors showcasing a broad overview of the significant scientific developments occurring in each field, OneMedForum has added other significant features to the Forum.

Panels consisting of leading strategic and financial investors will be followed by short presentations by promising companies. Over 100 companies will present.

Our first China Forum last year attracted over 100 top US and Chinese Healthcare investors and executives. This year, China Forum II will be invaluable to anyone seeking to capitalize on this booming market eager for Western brands and technology. If appropriate your company can partake in our new program to connect with Chinese investors and strategic partners at 1 pm on January 9th.

Another promising Asian market is India. Regulatory and market changes have created significant opportunities for biotech and medtech companies. An expert panel on India will be held at 4 pm on January 11th.

Because of rapid growth in the healthtech sector, we will hold a separate HealthTech meeting focused on how these new information technologies impact the medtech and biotech industries. Held the morning of January 12, this session will include short presentations by the fastest growing healthtech companies. (tickets need to be purchased separately).

Ten of the country’s top universities will be showcasing medical technologies that have gone through the rigorous “Coulter Process,” and thus ready for commercialization and to meet financial and strategic partners.

We have enhanced our 1×1 meeting system and will have meeting rooms and general networking areas to facilitate. As always, there will be excellent networking with receptions each night of the conference.

For more about OneMedForum SF 2012 visit http://www.onemedplace.com/forum/

For information about presenting or sponsorship opportunities, please contact us at onemedforum@onemedplace.com

The comments are closed.